Alan Landay to HIV Antibodies
This is a "connection" page, showing publications Alan Landay has written about HIV Antibodies.
Connection Strength
0.809
-
An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin Immunol Immunopathol. 1993 Oct; 69(1):106-16.
Score: 0.118
-
Complement-mediated, antibody-dependent neutralizing titers of sera from asymptomatic and symptomatic HIV-infected individuals. AIDS. 1992 Sep; 6(9):1047.
Score: 0.110
-
Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. Clin Vaccine Immunol. 2009 Apr; 16(4):499-505.
Score: 0.086
-
Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol. 2006 Nov; 48(2):267-73.
Score: 0.073
-
Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004 Dec 01; 190(11):1970-8.
Score: 0.064
-
Recent observations on HIV type-1 infection in the genital tract of men and women. AIDS. 2003 Mar 07; 17(4):455-80.
Score: 0.057
-
Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women. J Infect Dis. 2002 Feb 15; 185(4):439-47.
Score: 0.053
-
Vaccines and immunology. Recent advances in HIV/AIDS vaccine development. AIDS. 2001; 15 Suppl 5:S101-3.
Score: 0.049
-
Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy. PLoS One. 2017; 12(7):e0180245.
Score: 0.038
-
Anti-cellular antibodies in sera from vaccinated macaques can induce complement-mediated virolysis of human immunodeficiency virus and simian immunodeficiency virus. Virology. 1993 Aug; 195(2):475-80.
Score: 0.029
-
Complement and antibody mediate enhancement of HIV infection by increasing virus binding and provirus formation. AIDS. 1991 Mar; 5(3):269-74.
Score: 0.025
-
2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals. AIDS. 1991 Mar; 5(3):289-93.
Score: 0.025
-
Activation of complement on the surface of cells infected by human immunodeficiency virus. J Immunol. 1990 Feb 15; 144(4):1490-6.
Score: 0.023
-
Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome. JAMA. 1987 Sep 04; 258(9):1196-9.
Score: 0.019
-
Alteration of complement protein levels after antiretroviral therapy in HIV-infected persons. AIDS Res Hum Retroviruses. 1999 Dec 10; 15(18):1713-5.
Score: 0.011
-
Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers. Infect Control Hosp Epidemiol. 1999 Jun; 20(6):428-30.
Score: 0.011
-
Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 01; 16(3):161-8.
Score: 0.010
-
HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood. JAMA. 1994 Jan 05; 271(1):42-6.
Score: 0.008